MBIO:NASDAQ
Mustang Bio Inc
$0.46
arrow_downward
-1.09%(-0.0050) 1D
Oct 7, 11:50:28 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.46
High
$0.46
Low
$0.45
Mkt. cap
3.45M
Avg. vol.
25.87K
Volume
8.60K
52-wk high
$1.84
52-wk low
$0.45
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.46
High
$0.46
Low
$0.45
Mkt. cap
3.45M
Avg. vol.
25.87K
Volume
8.60K
52-wk high
$1.84
52-wk low
$0.45
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
AD HOC NEWS
·
13 hours ago
MBIO stock sits near its 52-week low as Nasdaq deadline nears
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com